Inmaculada (Inma) Hernández
@ihdezdelso
Professor @UCSanDiego; @theNAMedicine Fellow. Research to improve transparency in the pharma market, advance equity in drug access, and improve patient outcomes
ID: 463190035
https://profiles.ucsd.edu/inmaculada.hernandezydelso 13-01-2012 20:43:14
7,7K Tweet
2,2K Followers
895 Following
Thrilled to see that our paper on pharmacy access was the top cited paper published in Journal of the American Pharmacists Association in 2021-2022 Lucas Berenbrok UC San Diego Skaggs School of Pharmacy Pitt Pharmacy School
On 7/25, Duke-Margolis will host a virtual convening on real-world evidence policy. The event is open for registration, with an incredible lineup of speakers I will be discussing use of RWE on pricing, coverage and payment healthpolicy.duke.edu/events/2024-st…
After almost a year of planning, the San Diego outreach clinics are preparing to launch! In collaboration, UC San Diego Skaggs School of Pharmacy, SD County HHS Agency (Livewell and Pharmacy Services) will host a series of Community Health and Wellness Clinics at the El Cajon Library! Join us!
Over the last several years, 20+ states have implemented insulin OOP caps for commercial enrollees. Using a time-varying difference-in-differences design, we find that commercial insulin OOP caps do not significantly increase insulin use. Brett McQueen healthaffairs.org/doi/abs/10.137…
The numbers that many are wondering about - how did Medicare negotiated prices (MFPs) compare to the net prices before negotiation? Out in Health Affairs forefront now! healthaffairs.org/content/forefr…
In their new Forefront article Inmaculada (Inma) Hernández Olivier Wouters, Emma M. Cousin, Ayuri S. Kirihennedige + Sean D. Sullivan of UC San Diego LSE Health Policy + UW School of Pharmacy discuss CMSGov's recently-released negotiated prices, or Maximum Fair Prices, for 10 new drugs. bit.ly/3XnNFcY